Search Within

Ahmet Dogan

Formats
  1. Meeting Abstract (242)
  2. Journal Article (166)
  3. Research Letter (20)
  4. Review (16)
  5. Book Section (14)
  6. Guidelines (5)
  7. Editorial (4)
  8. Correspondence (2)
  9. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (470)
  2. Department of Medicine (315)
  3. Hematologic Malignancies, Division of (313)
  4. Center for Hematologic Malignancies (307)
  5. Sloan Kettering Institute Postdocs (180)
  6. Lymphoma (171)

More Groups

People
  1. Steven Horwitz (101)
  2. Mikhail Roshal (98)
  3. Maria Arcila (91)
  4. Andrew Zelenetz (81)
  5. Alison Moskowitz (78)
  6. Anita Kumar (64)

More People

Years
  1. 2025 (17)
  2. 2024 (47)
  3. 2023 (56)
  4. 2022 (33)
  5. 2021 (38)
  6. 2020 (59)

More Years

Publications
  1. Blood (135)
  2. Laboratory Investigation (47)
  3. Modern Pathology (36)
  4. Journal of Clinical Oncology (15)
  5. Haematologica (14)
  6. Journal of Molecular Diagnostics (14)

More Publications

Publishers
  1. American Society of Hematology (147)
  2. Nature Publishing Group (74)
  3. Nature Research (38)
  4. Wiley Blackwell (27)
  5. American Society of Clinical Oncology (19)
  6. Elsevier Inc. (17)

More Publishers

Results (470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy
    Meeting Abstract

    Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revealing novel mechanisms underlying inactivation of tumor suppressor genes on duplicated chromosomes in multiple myeloma
    Meeting Abstract

    Cirrincione, A.; Kaddoura, M.; Poos, A. M.; Ziccheddu, B.; Maclachlan, K. H.; Chojnacka, M.; Diamond, B.; Blaney, P.; Gagler, D.; Zhang, Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Polytypic B-cells, B-cell lymphoproliferative disorders/lymphomas, and neoplastic T-cells divergently differentiate from TET2-/ DNMT3A-mutated clonal hematopoiesis in patients with follicular helper T-cell lymphomas/lymphoproliferative disorders
    Meeting Abstract

    Lewis, N.; Petrova-Drus, K.; Sardana, R.; Gao, Q.; Sethi, S.; Xiao, W.; Roshal, M.; Baik, J.; Bhurtel, H.; Moskowitz, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ruxolitinib promotes clinical responses in large granular lymphocytic leukemia via suppression of JAK/STAT-dependent inflammatory cascades
    Meeting Abstract

    Moskowitz, A.; Rahman, J.; Ganesan, N.; Hannigan, K.; Ksanznak, K.; Bitton, H.; Lin, Y. H.; Davey, T.; Hancock, H.; Perez, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms
    Meeting Abstract

    Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patient selection using genetic alterations associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Lee, J.; Fregonese, B.; Tringale, K.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Biology and genetics of extranodal mature T-cell and NK-cell lymphomas and lymphoproliferative disorders
    Review

    Lewis, N. E.; Zhou, T.; Dogan, A.
    Haematologica (2023)

    Fulltext@MSK | Save